Skip to main content
icon for Which countries will have an Ebola case in 2026?

Which countries will have an Ebola case in 2026?

icon for Which countries will have an Ebola case in 2026?

Which countries will have an Ebola case in 2026?

$14,857 Vol.

31. Dez. 2026
Polymarket

$14,857 Vol.

Polymarket

South Sudan

$596 Vol.

67%

Rwanda

$151 Vol.

60%

Burundi

$157 Vol.

49%

United States

$4,262 Vol.

34%

Canada

$817 Vol.

26%

Kenya

$134 Vol.

60%

India

$384 Vol.

27%

Republic of the Congo

$4,405 Vol.

23%

Nigeria

$17 Vol.

33%

Ethiopia

$57 Vol.

51%

Somalia

$59 Vol.

27%

China

$1,861 Vol.

31%

This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred. The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.The ongoing Bundibugyo virus outbreak, first confirmed in May 2026 in Ituri Province of the Democratic Republic of the Congo and linked to cases in Uganda, serves as the dominant driver of market expectations for 2026 Ebola detections. As of early June, DRC authorities report over 600 confirmed cases with substantial suspected totals, while Uganda has documented around 19 confirmed infections, prompting a WHO-declared public health emergency of international concern. This Bundibugyo strain, distinct from more common Zaire ebolavirus, carries a historical case fatality rate of 30-50% and spreads via direct contact with bodily fluids, with elevated transmission risks in insecure, high-mobility border regions. Neighboring countries face heightened scrutiny through enhanced surveillance by ministries of health and organizations like the CDC and Africa CDC, though no additional nations have reported cases to date. Resolution hinges on laboratory-confirmed detections through year-end, with forthcoming weekly epidemiological updates and contact-tracing data likely to influence spread assessments.

This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.

The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Volumen
$14,857
Enddatum
31. Dez. 2026
Markt eröffnet
May 22, 2026, 12:35 PM ET
This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred. The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred. The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.The ongoing Bundibugyo virus outbreak, first confirmed in May 2026 in Ituri Province of the Democratic Republic of the Congo and linked to cases in Uganda, serves as the dominant driver of market expectations for 2026 Ebola detections. As of early June, DRC authorities report over 600 confirmed cases with substantial suspected totals, while Uganda has documented around 19 confirmed infections, prompting a WHO-declared public health emergency of international concern. This Bundibugyo strain, distinct from more common Zaire ebolavirus, carries a historical case fatality rate of 30-50% and spreads via direct contact with bodily fluids, with elevated transmission risks in insecure, high-mobility border regions. Neighboring countries face heightened scrutiny through enhanced surveillance by ministries of health and organizations like the CDC and Africa CDC, though no additional nations have reported cases to date. Resolution hinges on laboratory-confirmed detections through year-end, with forthcoming weekly epidemiological updates and contact-tracing data likely to influence spread assessments.

This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.

The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Volumen
$14,857
Enddatum
31. Dez. 2026
Markt eröffnet
May 22, 2026, 12:35 PM ET
This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred. The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.

Vorsicht bei externen Links.

Häufig gestellte Fragen

„Which countries will have an Ebola case in 2026?" ist ein Prognosemarkt auf Polymarket mit 13 möglichen Ergebnissen, bei dem Händler Anteile auf Basis ihrer Einschätzung kaufen und verkaufen. Das aktuell führende Ergebnis ist „Uganda" mit 100%, gefolgt von „South Sudan" mit 67%. Die Preise spiegeln Echtzeit-Wahrscheinlichkeiten der Community wider. Ein Anteilspreis von 100¢ bedeutet, dass der Markt diesem Ergebnis eine Wahrscheinlichkeit von 100% zuweist. Diese Quoten ändern sich laufend, wenn Händler auf neue Entwicklungen reagieren. Anteile am richtigen Ergebnis können bei Marktauflösung für jeweils $1 eingelöst werden.

Stand heute hat „Which countries will have an Ebola case in 2026?" ein Gesamthandelsvolumen von $14.9K generiert, seit der Markt am May 22, 2026 gestartet wurde. Dieses Aktivitätsniveau spiegelt starkes Engagement der Polymarket-Community wider und stellt sicher, dass die aktuellen Quoten von einem breiten Pool an Marktteilnehmern geprägt werden. Sie können Live-Preisbewegungen verfolgen und direkt auf dieser Seite auf jedes Ergebnis handeln.

Um auf „Which countries will have an Ebola case in 2026?" zu handeln, durchsuchen Sie die 13 verfügbaren Ergebnisse auf dieser Seite. Jedes Ergebnis zeigt einen aktuellen Preis, der die implizierte Wahrscheinlichkeit des Marktes darstellt. Um eine Position einzunehmen, wählen Sie das Ergebnis, das Sie für am wahrscheinlichsten halten, wählen Sie „Ja" um dafür oder „Nein" um dagegen zu handeln, geben Sie Ihren Betrag ein und klicken Sie auf „Handeln". Liegt Ihr gewähltes Ergebnis bei Marktauflösung richtig, zahlen Ihre „Ja"-Anteile jeweils $1 aus. Liegt es falsch, zahlen sie $0. Sie können Ihre Anteile auch jederzeit vor der Auflösung verkaufen.

Der aktuelle Favorit für „Which countries will have an Ebola case in 2026?" ist „Uganda" mit 100%, was bedeutet, dass der Markt diesem Ergebnis eine Wahrscheinlichkeit von 100% zuweist. Das nächstliegende Ergebnis ist „South Sudan" mit 67%. Diese Quoten werden in Echtzeit aktualisiert, wenn Händler Anteile kaufen und verkaufen. Schauen Sie regelmäßig vorbei oder speichern Sie diese Seite als Lesezeichen.

Die Auflösungsregeln für „Which countries will have an Ebola case in 2026?" definieren genau, was passieren muss, damit jedes Ergebnis als Gewinner erklärt wird – einschließlich der offiziellen Datenquellen zur Bestimmung des Ergebnisses. Sie können die vollständigen Auflösungskriterien im Abschnitt „Regeln" auf dieser Seite über den Kommentaren einsehen. Wir empfehlen, die Regeln vor dem Handeln sorgfältig zu lesen, da sie die genauen Bedingungen, Sonderfälle und Quellen festlegen.